This inventor holds 1 USPTO granted patent. Top assignees: Dongguk University Industry-Academic Cooperation Foundation, Korea Research Institute of Bioscience and Biotechnology. Active years: 2016.
Company Filing History:
1 out of 102 
1 out of 334 
Years Active: 2016
Title: Seohyun Son: Innovator in Cancer Treatment
Introduction
Seohyun Son, an esteemed inventor located in Goyang-si, South Korea, has made significant contributions to the field of pharmaceuticals. With a focus on anticancer compositions, he holds one patent that showcases his innovative approach to cancer treatment.
Latest Patents
Seohyun Son's patent, titled "Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, production method for same, and pharmaceutical composition for suppressing cancer metastasis comprising same as active ingredient," presents a novel disubstituted adamantyl derivative. This invention not only describes the compound and its production method but also highlights its pharmaceutical applications in suppressing cancer metastasis. The derivative effectively inhibits the expression of metastasis-related proteins and genes without cytotoxic effects, making it a promising candidate for anticancer therapies.
Career Highlights
Throughout his career, Seohyun Son has collaborated with prominent institutions, contributing to vital research in the field of bioscience and biotechnology. He has been affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he engaged in innovative research that paved the way for his groundbreaking patent. Additionally, he has been associated with the Dongguk University Industry-Academic Cooperation Foundation, facilitating the transfer of knowledge and technology between academia and industry.
Collaborations
Seohyun Son has worked alongside distinguished colleagues, including Mi Sun Won and Kyeong Seok Lee. Together, they have fostered an environment of innovation and collaboration, further enhancing their contributions to cancer research and potential treatments.
Conclusion
Seohyun Son's inventive spirit and dedication to cancer research are evident in his patent for a disubstituted adamantyl derivative. His work not only holds promise for advancing pharmaceutical compositions but also highlights the importance of collaboration in scientific advancements. As he continues to develop innovative solutions, the medical community awaits his contributions with great anticipation.